Compare Sun Pharma with SANDU PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs SANDU PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA SANDU PHARMA SUN PHARMA/
SANDU PHARMA
 
P/E (TTM) x 29.0 19.8 146.7% View Chart
P/BV x 3.9 1.0 396.2% View Chart
Dividend Yield % 1.0 1.1 90.0%  

Financials

 SUN PHARMA   SANDU PHARMA
EQUITY SHARE DATA
    SUN PHARMA
Mar-21
SANDU PHARMA
Mar-21
SUN PHARMA/
SANDU PHARMA
5-Yr Chart
Click to enlarge
High Rs65444 1,495.9%   
Low Rs33912 2,941.8%   
Sales per share (Unadj.) Rs139.674.2 188.2%  
Earnings per share (Unadj.) Rs9.51.4 690.6%  
Cash flow per share (Unadj.) Rs18.22.1 873.7%  
Dividends per share (Unadj.) Rs7.500.50 1,500.0%  
Avg Dividend yield %1.51.8 83.5%  
Book value per share (Unadj.) Rs193.641.2 470.6%  
Shares outstanding (eoy) m2,399.347.92 30,294.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.60.4 954.9%   
Avg P/E ratio x52.120.0 260.3%  
P/CF ratio (eoy) x27.313.3 205.7%  
Price / Book Value ratio x2.60.7 381.9%  
Dividend payout %78.836.3 217.2%   
Avg Mkt Cap Rs m1,190,430219 544,420.6%   
No. of employees `000NANA-   
Total wages/salary Rs m68,62280 85,585.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m334,981588 57,013.3%  
Other income Rs m8,5922 445,165.8%   
Total revenues Rs m343,573589 58,283.1%   
Gross profit Rs m41,61622 192,755.0%  
Depreciation Rs m20,8006 373,420.1%   
Interest Rs m1,4141 122,982.6%   
Profit before tax Rs m27,99417 166,530.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,1476 87,532.3%   
Profit after tax Rs m22,84711 209,219.8%  
Gross profit margin %12.43.7 338.1%  
Effective tax rate %18.435.0 52.5%   
Net profit margin %6.81.9 366.8%  
BALANCE SHEET DATA
Current assets Rs m304,421305 99,669.6%   
Current liabilities Rs m161,456125 128,969.0%   
Net working cap to sales %42.730.7 139.1%  
Current ratio x1.92.4 77.3%  
Inventory Days Days1492 9,749.6%  
Debtors Days Days9933,221,694 0.0%  
Net fixed assets Rs m336,682164 205,043.9%   
Share capital Rs m2,39979 3,029.0%   
"Free" reserves Rs m462,229247 187,364.6%   
Net worth Rs m464,628326 142,563.2%   
Long term debt Rs m8,9810-   
Total assets Rs m641,103470 136,512.3%  
Interest coverage x20.815.6 133.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.51.3 41.8%   
Return on assets %3.82.6 147.2%  
Return on equity %4.93.4 146.7%  
Return on capital %6.25.5 112.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m84,4930-   
Fx outflow Rs m30,3340-   
Net fx Rs m54,1590-   
CASH FLOW
From Operations Rs m61,70476 81,296.0%  
From Investments Rs m5,362-56 -9,616.6%  
From Financial Activity Rs m-59,80513 -461,101.0%  
Net Cashflow Rs m5,96433 18,013.3%  

Share Holding

Indian Promoters % 54.5 45.0 121.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.8 0.0 338,000.0%  
FIIs % 12.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 45.5 55.0 82.8%  
Shareholders   675,908 10,508 6,432.3%  
Pledged promoter(s) holding % 6.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   LUPIN  CIPLA  AUROBINDO PHARMA  DR. REDDYS LAB  CADILA HEALTHCARE  



Today's Market

RBI Monetary Policy Highlights, Airtel's Big Step Towards Broadband Expansion, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a strong note yesterday. The bulls continued to roar on the Dalal Street, as the key benchmark indices logged back-to-back strong gains.

Related Views on News

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

6 Penny Stocks that Rallied 1,000%+ in One Year(Views On News)

Dec 6, 2021

These penny stocks shed their penny status by surging 1,000% or more in the last one year.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Dec 8, 2021 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS